Abstract

A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing

Author(s): Riepl Mike

Issue: Nov/Dec 2022 - Volume 26, Number 6

Page(s): 480-488

Download in electronic PDF format for $75
  • A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Page 1
  • A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Page 2
  • A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Page 3
  • A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Page 4
  • A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Page 5
  • A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Page 6
  • A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Page 7
  • A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Page 8
  • A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Page 9

Abstract

Skin injuries, whether acute or chronic, can present therapeutic challenges engendered by wound type and etiology as well as the pharmacogenomic profile and treatment preferences of the patient. As a result, standardized manufactured medications may fail to promote healing or their use may prove intolerable (complications that impose a burden on patients and ultimately on the society in which they live and the healthcare system that supports them). For cases in which commercially available wound-healing products fail or cannot be used, a uniquely formulated pharmaceutical compound may be effective. In this article, the differences between acute and chronic dermal injuries are presented, wound infection is discussed, specific compounds designed to treatment some of the most challenging dermal-wound types are listed, and two complete formulations that have also proven safe and effective in promoting the healing of external skin damage are provided.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2004
Pg. 269-274
Nov/Dec 2022
Pg. 480-488
Author(s): Riepl Mike
Mar/Apr 2002
Pg. 92-95
Author(s): Kincaid Michele R
Jul/Aug 2021
Pg. 282-287
Author(s): Riepl Mike
Jul/Aug 2020
Pg. 282-285
Author(s): Riepl Mike
Jul/Aug 2020
Pg. 278-281
Author(s): Riepl Mike
Mar/Apr 2021
Pg. 100-103
Author(s): Riepl Mike
Sep/Oct 2021
Pg. 372-377
Author(s): Riepl Mike
May/Jun 2020
Pg. 188-193
Author(s): Riepl Mike
Nov/Dec 2021
Pg. 468-472
Author(s): Riepl Mike
Nov/Dec 2020
Pg. 501-508
Sep/Oct 2022
Pg. 364-368
Author(s): Riepl Mike
Jul/Aug 2022
Pg. 270-274
Author(s): Riepl Mike
Mar/Apr 2018
Pg. 154-163
Nov/Dec 2023
Pg. 454-460
May/Jun 2009
Pg. 196-213
Jan/Feb 2022
Pg. 18-23
Author(s): Riepl Mike
Mar/Apr 2022
Pg. 94-98
Author(s): Riepl Mike
May/Jun 2018
Pg. 182-188
Mar/Apr 2020
Pg. 98-102
Author(s): Riepl Mike